September 2026 — Beijing/Washington — China and the United States have reached consensus on a new reciprocal tariff reduction framework covering approximately US$30 billion of imports from each country, marking a new development in bilateral economic and trade relations. Among the products included in China’s tariff-reduction list are medical devices, along with agricultural products, personal care products, and coal.

The agreement was reached during the eighth round of China-U.S. economic and trade consultations held from September 20 to 23 in New York and Washington, D.C. According to China’s Ministry of Commerce, the two sides agreed to provide reciprocal tariff-reduction treatment for approximately US$30 billion worth of imported products from each country, subject to their respective domestic legal procedures. More than 90 percent of the products covered are expected to have the additional tariffs imposed on them removed and receive most-favored-nation tariff treatment.

Medical Devices Included in China’s Tariff Reduction List

One of the notable elements of the arrangement is the inclusion of medical devices among the U.S. products covered by China’s tariff reduction list.

China's Ministry of Commerce stated that the Chinese list includes agricultural products, personal care products, medical devices, coal and other categories of goods. The U.S. Trade Representative also identified medical devices among the product categories included in the reciprocal framework.

The inclusion of medical devices could be relevant to manufacturers, distributors, hospitals, laboratories, research institutions, and other participants in the medical and healthcare supply chain. Depending on the specific products covered and the final implementation procedures, tariff adjustments may affect the import costs and trade conditions of certain U.S.-origin medical equipment entering the Chinese market.

However, the tariff framework does not mean that all U.S. medical devices will automatically receive the same treatment. The detailed product list and applicable tariff codes determine whether a specific product qualifies for the reduction. Companies involved in cross-border medical-device trade will therefore need to review the official product list and relevant customs classifications carefully.

Approximately $30 Billion of Products on Each Side

Under the framework, the United States will reduce tariffs on approximately US$30 billion worth of Chinese imports. Products identified by the Chinese Ministry of Commerce include toys, household appliances, baby products, kitchen and bathroom goods, and holiday gifts.

At the same time, China will reduce tariffs on approximately US$30 billion worth of U.S. imports, covering agricultural products, personal care products, medical devices, coal and other goods. The two sides have agreed to jointly release their respective lists of products covered by the tariff reductions.

The U.S. list reportedly contains 77 product categories, while China's list contains 1,619 categories of U.S. goods. The categories entering China include agricultural commodities, personal care products, medical equipment and energy-related products.

Implementation Will Follow Domestic Procedures

Although the two countries have reached consensus on the framework and product lists, implementation is subject to each country's domestic legal and procedural requirements.

China's Ministry of Commerce said the tariff reductions will be implemented simultaneously after the relevant domestic procedures have been completed by both sides. This means companies should distinguish between the announcement of the framework and the actual effective date of the tariff adjustments.

For medical-device companies, this distinction is particularly important. Importers and distributors should continue to follow existing customs, regulatory, registration, quality, and product-compliance requirements until the new tariff treatment formally takes effect.

Potential Implications for the Medical Equipment Industry

The inclusion of medical devices in the framework has attracted attention from the medical technology and laboratory-equipment sectors. The United States is an important supplier of medical and scientific equipment, while China has a large and diversified healthcare, pharmaceutical, biotechnology, and research market.

If applicable tariff reductions lower the landed cost of eligible products, distributors and end users could see changes in procurement economics. Potentially affected products may include certain categories of diagnostic equipment, imaging-related equipment, laboratory equipment, and other medical technologies, depending on the final tariff classifications.

For hospitals and research laboratories, changes in import costs could become one factor in equipment procurement and budgeting. For manufacturers and distributors, the framework may encourage closer examination of supply-chain strategies, inventory planning, pricing structures, and cross-border distribution arrangements.

It is important, however, not to assume that tariff changes alone will determine the commercial impact. Medical devices remain subject to applicable regulatory, registration, customs, certification, and market-access requirements.

A Broader Mechanism for Trade Cooperation

The tariff framework is part of a broader institutional development in China-U.S. economic relations. The two countries agreed to establish a China-U.S. Board of Trade under their economic and trade consultation mechanism, with the primary objective of optimizing bilateral trade.

The two sides also agreed to establish an agricultural working group to discuss market access, regulatory issues, and other agricultural trade concerns. In addition, a China-U.S. Board of Investment was agreed upon to provide a structured platform for discussions concerning investment opportunities and barriers.

These mechanisms indicate that tariff adjustments are being addressed alongside broader discussions concerning trade, agriculture, investment, market access, and regulatory cooperation.

What Medical Device Companies Should Watch

For companies engaged in U.S.-China medical-device trade, several issues will require close attention in the coming period.

First, businesses should verify whether their specific products appear on the final tariff-reduction list. Second, companies should confirm the applicable customs tariff codes and country-of-origin requirements. Third, importers should monitor the official implementation date and corresponding customs procedures.

Medical-device companies should also distinguish tariff treatment from regulatory approval. A reduction in import tariffs does not eliminate requirements relating to product registration, quality management, safety, labeling, customs documentation, or other applicable regulations.

Conclusion

The newly announced US$30 billion-for-US$30 billion reciprocal tariff reduction framework represents a significant development in China-U.S. trade relations. With medical devices included among the products on China's tariff-reduction list, the arrangement has particular relevance for the medical technology, laboratory equipment, pharmaceutical, healthcare, and scientific research sectors.

According to the two governments, more than 90 percent of the products covered by the framework are expected to receive most-favored-nation tariff treatment after the necessary domestic procedures are completed. The practical impact on individual companies will depend on the final product lists, tariff classifications, implementation dates, and applicable regulatory requirements.

For medical-device manufacturers, distributors, hospitals, laboratories, and other industry participants, the next step will be to closely monitor the official implementation details and assess how the tariff changes may affect procurement costs, supply chains, pricing, and cross-border trade strategies.